Prague hereditary hypercholesterolemic (PHHC) rat - a model of polygenic hypercholesterolemia
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
20131941
DOI
10.33549/physiolres.931916
PII: 931916
Knihovny.cz E-resources
- MeSH
- Atherosclerosis genetics metabolism pathology MeSH
- Cholesterol, Dietary adverse effects MeSH
- Cholesterol blood MeSH
- Phenotype MeSH
- Genetic Predisposition to Disease MeSH
- Hybridization, Genetic MeSH
- Hypercholesterolemia blood genetics pathology MeSH
- Liver metabolism pathology MeSH
- Rats MeSH
- Lipoproteins blood MeSH
- Disease Models, Animal MeSH
- Multifactorial Inheritance MeSH
- Rats, Wistar MeSH
- Disease Progression MeSH
- Fatty Liver genetics metabolism pathology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Cholesterol, Dietary MeSH
- Cholesterol MeSH
- Lipoproteins MeSH
Prague hereditary hypercholesterolemic (PHHC) rat - rat strain crossbred from Wistar rats - is a model of hypercholesterolemia induced by dietary cholesterol. Importantly, no bile salts and/or antithyroid drugs need to be added to the diet together with cholesterol to induce hypercholesterolemia. PHHC rats have only modestly increased cholesterolemia when fed a standard chow and develop hypercholesterolemia exceeding 5 mmol/l on 2 % cholesterol diet. Most of the cholesterol in hypercholesterolemic PHHC rats is found in VLDL that become enriched with cholesterol (VLDL-C/VLDL-TG ratio > 1.0). Concurrently, both IDL and LDL concentrations rise without any increase in HDL. PHHC rats do not markedly differ from Wistar rats in the activities of enzymes involved in intravascular remodelation of lipoproteins (lipoprotein and hepatic lipases and lecithin:cholesterol acyltransferase), LDL catabolism, cholesterol turnover rate and absorption of dietary cholesterol. The feeding rats with cholesterol diet results in development of fatty liver in spite of suppression of cholesterol synthesis. However, even though cholesterolemia in PHHC rats is comparable to human hypercholesterolemia, the PHHC rats do not develop atherosclerosis even after 6 months on 2 % cholesterol diet. Importantly, the crossbreeding experiments documented that hypercholesterolemia of PHHC rats is polygenic. To identify the genes that may be involved in pathogenesis of hypercholesterolemia in this strain, the studies of microarray gene expression in the liver of PHHC rats are currently in progress.
References provided by Crossref.org
Global DNA methylation in rats´ liver is not affected by hypercholesterolemic diet
Experimental models of non-alcoholic fatty liver disease in rats